Open AccessSTUDY OF IMMUNE RESPONSE AFTER HEPATITIS B VACCINATION IN DOCTORS
Author(s) -
Babu Lal Meena,
Nikhil Gandhi,
Mamta Sharma
Publication year - 2020
Publication title -
international journal of medical and biomedical studies
Language(s) - English
Resource type - Journals
eISSN - 2589-8698
pISSN - 2589-868X
DOI - 10.32553/ijmbs.v4i6.1219
Subject(s) - vaccination , medicine , hepatitis b , booster dose , titer , booster (rocketry) , hepatitis b vaccine , age groups , immunology , hepatitis a vaccine , hepatitis , hepatitis a , pediatrics , hepatitis b virus , demography , antibody , hbsag , virus , physics , astronomy , sociology
Background: Aim of our study was to evaluate the immune response after hepatitis B vaccination and to determine the duration of protective levels of HBsAb titre in doctors. From our study we concluded that hepatitis-B vaccine gives protection for more than 10 years after primary vaccination and booster dose of Hepatitis-B vaccine is not required in immunocompetent persons after primary vaccination.
Method: In this study total 100 doctors of our institution were included who were vaccinated against hepatitis B. Data were obtained regarding age, sex, weight, height, BMI and duration of vaccination period. Doctors with no prior vaccination or incomplete vaccination or those who took booster vaccination were excluded from this study.
Results: The mean titre was observed to be higher in 30 to 34 years of age group (584.42±4.03.21) as compared to age group of less than 25 and greater than 40 years. Moreover, males were observed to have higher mean titre as compared to females. (411.64± 417.27 vs 333.66± 431.49) but not statistically significant. Similar with age and sex, duration of vaccination status was also not statistically significant. When we compared the duration of vaccination status with age group , mean titre was more in ≥30 years of age group as compared to <30 years (younger age groups) but statistically significant relation was observed only with the 1 month to <5 years of duration.
Conclusion: From our study we concluded that hepatitis-B vaccinegives protection for more than 10 years after primary vaccination and booster dose of Hepatitis-B vaccine is not required inimmuno-competent persons after primary vaccination.
Keywords: HbsAg titre , HepatitsB vaccine , seroprotection rate.